Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis (NYSE: ENOV) management will present at the Annual Jefferies Global Healthcare Conference in London on November 17, 2026.
The presentation is scheduled for 11:30 a.m. GMT (6:30 a.m. ET). A live audio webcast and replay will be available on the company’s website under Investors, Events and Presentations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 11:30 a.m. GMT (6:30 a.m. ET).
A link to the live audio webcast, as well as a replay of the event, will be available on the Company’s website under the Investors tab at Events and Presentations.
About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.
Investor Contact
Kyle Rose, Vice President, Investor Relations
investorrelations@enovis.com
Media Contact
Rachel Colloff, Sr. Director, Corporate Communications
Rachel.Colloff@enovis.com